Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
75.6M
-
Number of holders
-
134
-
Total 13F shares, excl. options
-
66.5M
-
Shares change
-
+2.83M
-
Total reported value, excl. options
-
$1.72B
-
Value change
-
+$69.5M
-
Put/Call ratio
-
0.04
-
Number of buys
-
66
-
Number of sells
-
-63
-
Price
-
$26.01
Significant Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX) as of Q4 2022
167 filings reported holding SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q4 2022.
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX) has 134 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66.5M shares
of 75.6M outstanding shares and own 87.89% of the company stock.
Largest 10 shareholders include FMR LLC (9.36M shares), ORBIMED ADVISORS LLC (5.25M shares), Bain Capital Life Sciences Investors, LLC (4.83M shares), VANGUARD GROUP INC (4.32M shares), STATE STREET CORP (3.76M shares), EcoR1 Capital, LLC (3.46M shares), Boxer Capital, LLC (3.42M shares), BlackRock Inc. (3.32M shares), Deep Track Capital, LP (3.11M shares), and PERCEPTIVE ADVISORS LLC (2.62M shares).
This table shows the top 134 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.